Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma

Sayegh, N; Tripathi, N; Agarwal, N; Swami, U

Swami, U (通讯作者)，Univ Utah NCI CCC, Huntsman Canc Inst, Div Oncol, 2000 Circle Hope Dr Res North Bldg Suite 2121, Salt Lake City, UT 84112 USA.

ONCOTARGETS AND THERAPY, 2022; 15 (): 1047

Abstract

Erdafitinib received accelerated approval on April 12, 2019, for patients with metastatic or locally advanced urothelial carcinoma with susceptible fi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索